Compare Davita Inc (DVA) vs JPMorgan Diversified Return International Eqty ETF (JPIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs JPMorgan Diversified Return International Eqty ETF — how do they compare? Davita Inc trades at $180 (market cap $11.58B), while JPMorgan Diversified Return International Eqty ETF trades at $77. The key difference: JPMorgan Diversified Return International Eqty ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals.
| DVA | JPIN | |
|---|---|---|
Market Cap | $11.58B | — |
Sector | Health | — |
52-Week High | $240.96 | $77.00 |
52-Week Low | $103.87 | $64.96 |
Enterprise Value | $24.30B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $179.17, showing modest daily gains of 0.47% amid bearish technical signals. The stock demonstrates strong fundamental performance with consistent earnings beats (Q2 2026 EPS of $4.02 vs. $3.88 expected) and attractive valuation metrics including P/E of 15.38 and P/S of 0.91. Recent news highlights volume growth momentum but concerns about narrowing margins and reimbursement pressures. Analyst consensus remains positive with a $232.25 price target representing 30% upside potential from current levels.
The outlook remains cautiously optimistic given DVA's strong earnings track record and institutional support, though investors face risks from reimbursement pressure, high debt levels (debt-to-asset ratio of 65.55% in 2025), and mixed technical indicators. The stock's current valuation presents opportunity if margin pressures ease and volume growth continues as projected through 2026.
JPIN (JPMorgan Diversified Return International Equity ETF) trades at $76.515, up 0.37% with a bullish technical signal. The ETF provides broad exposure to foreign large value stocks through a smart beta approach. Technical indicators show strong momentum with moving averages in bullish alignment, though RSI levels suggest potential overbought conditions. The fund's dividend policy includes a scheduled $0.91 distribution for June 2026.
The ETF's international value focus positions it for global diversification benefits, though foreign market volatility and currency risks remain considerations. Current technical strength supports near-term upside potential, but investors should monitor RSI levels for overbought signals. The fund's systematic approach to international value investing offers structured exposure to overseas markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About JPMorgan Diversified Return International Eqty ETF
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →
